Skip to main content
Premium Trial:

Request an Annual Quote

MRI Grows as the Place for Biotech Firms to Get Noticed

Premium

When Agilent’s automated lab-on-chip platform (ALP) Bioanalyzer 5100 underwent high-throughput screening at the Midwest Research Institute in December 2004, it joined a cadre of other technology companies that take advantage of MRI’s established profile as a reliable provider of testing for novel technologies.

The ALP is available as part of Invitrogen’s PATH Alert System, a microfluidic-based kit for chemical and biological threat agent detection, and Invitrogen and other companies have used MRI’s abilities to do “real-world testing” on their products before, spokespeople for the institute said.

According to Linda Cook, a spokesperson for MRI, the Kansas City, Mo.-based institute does not endorse new technologies, but rather is contracted by companies like Agilent to perform testing on technology that the company cannot do itself.

That lack of endorsement doesn’t mean that the performance of a technology of a product isn’t noted. According to Victor Truong, a spokesperson for Agilent, getting the ALP tested at MRI was part of a concentrated effort to make the technology, only available since November 2004, visible in places where it counts.

— JP

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.